Increased lipid droplet number and fatty acid synthesis allow glioblastoma multiforme, the most common and aggressive type of brain cancer, to withstand accelerated metabolic rates and resist therapeutic treatments. Lipid droplets are postulated to sequester hydrophobic therapeutic agents, thereby reducing drug effectiveness. We hypothesized that the inhibition of lipid droplet accumulation in glioblastoma cells using pyrrolidine-2, a cytoplasmic phospholipase A2 alpha inhibitor, can sensitize cancer cells to the killing effect of curcumin, a promising anticancer agent isolated from the turmeric spice. We observed that curcumin localized in the lipid droplets of human U251N glioblastoma cells. Reduction of lipid droplet number using pyrrolidine-2 drastically enhanced the therapeutic effect of curcumin in both 2D and 3D glioblastoma cell models. The mode of cell death involved was found to be mediated by caspase-3. Comparatively, the current clinical chemotherapeutic standard, temozolomide, was significantly less effective in inducing glioblastoma cell death. Together, our results suggest that the inhibition of lipid droplet accumulation is an effective way to enhance the chemotherapeutic effect of curcumin against glioblastoma multiforme.
Introduction
In cancers such as glioblastoma multiforme, enhanced fatty acid storage and synthesis provide the necessary resources for survival and rapid proliferation [1] . Although otherwise highly heterogeneous, most cancer types present a lipogenic phenotype characterized by the upregulation of key enzymes and transcriptional factors controlling lipid metabolism (e.g. Akt, fatty acid synthase, hypoxia-inducible factor 1-alpha, sterol regulatory element binding proteins, acetyl-CoA carboxylase alpha), and a boost in de novo lipogenesis [2] [3] [4] [5] . In solid malignancies, the hypoxic conditions found at the core of the tumors induce adaptive pathways aimed at maintaining lipid synthesis, homeostatic pH and cell survival [6] . The resulting metabolic changes correlate with poor prognosis, poor treatment response and recurrence in diseases such as breast, liver and brain cancer [7] [8] [9] [10] . Emerging therapeutic approaches have thus targeted lipid synthesis to counter the effects of metabolic reprogramming in cancer cells [11, 12] .
Aside from their increased de novo fatty acid synthesis, cancer cells are also characterized by their increased number of lipid droplets compared to normal tissues [13, 14] . Lipid droplets are dynamic organelles that support cells with metabolic fuel, membrane biosynthesis, inflammatory intermediates and signaling mediators [15] [16] [17] . Although they can be found in almost all cell types, their increased biogenesis in neoplastic and inflammatory conditions defines them as targets for therapeutic intervention [18] . Aside from fueling the accelerated metabolism of cancer cells, lipid droplets also harbor numerous proteins and transcription factors critical to lipid metabolism and related pathways [19] . The hydrophobic core found in lipid droplets provides a favorable compartment to attract and sequester lipophilic proteins and compounds, fat-soluble vitamins, and even environmental pollutants [20] . As such, lipid droplets can sequester lipophilic drugs and prevent them from reaching their targets, thus decreasing drug effectiveness [21, 22] . Therefore, it seems that inhibition by pharmacological or genetic means of enzymes necessary for lipid droplet formation could provide a way to reduce drug sequestration and improve drug effects. We tested this concept in glioblastoma cells treated with curcumin in combination with pyrrolidine-2, and inhibitor of cytosolic phospholipase A2 alpha (cPLA2a). Curcumin, a plant-derived polyphenol isolated from the turmeric spice, has been shown to be a safe, potent and effective anticancer agent both in vitro and in vivo [23] . It was found to affect multiple targets, leading to the inhibition of inflammation and cell proliferation [24] . Curcumin has a broad range of effects that are advantageous against multifactorial diseases such as cancer, and clinical trials have suggested biological activity in patients with colorectal and pancreatic cancer [25, 26] . Despite being welltolerated in humans, its poor bioavailability has limited prospects of broader clinical applications [26, 27] . Given its lipophilic properties, curcumin has been found to localize in lipid membranes and lipid droplets, thereby decreasing its availability at drug targets. Pyrrolidine-2, also known as pyrrophenone, is a potent and reversible inhibitor of cPLA2a, a key enzyme in the processes of arachidonic acid release, eicosanoid synthesis and lipid droplet formation [28, 29] . We hypothesize that pre-treatment of cancer cells with pyrrolidine-2 will enhance the cell killing effect of curcumin by reducing its sequestration in lipid droplets.
Glioblastoma multiforme is a highly aggressive and drugresistant type of brain cancer which currently lacks effective treatments [30, 31] . Temozolomide, a DNA methylating agent, is the first-line drug used in concomitant and adjuvant radiochemotherapy against glioblastoma [32] [33] [34] . However, a large subset of patients is resistant to temozolomide due to the expression of the O 6 -methylguanine-DNA methyltransferase gene (MGMT), a DNA repair protein, and there is an urgent need for alternative mono-and combination therapies [35] . We have investigated the susceptibility of human glioblastoma monolayer (2D) and spheroid (3D) cultures to curcumin and temozolomide used either individually or in combination with pyrrolidine-2. We also compared the effect of pyrrolidine-2 to that of buthionine sulfoximine (BSO), an irreversible inhibitor of gamma-glutamylcysteine synthetase, the rate-limiting enzyme in glutathione synthesis, found to be effective as a sensitizing agent in patient-derived neuroblastoma cell lines [36, 37] . We further monitored the mode of cell death induced by these treatments using a newly developed, dimerization-based biosensor which provides a highly sensitive method to visualize and quantify caspase-dependent apoptotic activity in living cells [38] . The cysteine protease caspase-3 is a main executioner caspase in the process of caspase-dependent apoptosis [39, 40] . It was shown to be strongly activated in response to curcumin treatment in different cell lines [41] [42] [43] . By investigating the activity of caspase-3 in cancer cells in response to chemotherapeutics and sensitizers, we can reveal drug efficacy and underlying mechanisms of cell death.
The objective of these studies was to investigate the sensitization of human glioblastoma cells in 2D and 3D cultures to caspase-3-mediated cell death induced by curcumin. We used the pharmacological agent pyrrolidine-2 to manipulate lipid droplet number in glioblastoma cells and assessed caspase-3 activity in living cells using a recently developed biosensor. The results indicate a significant increase in caspase-3-mediated cell death induced by curcumin when lipid droplet formation is reduced.
Materials and methods

Materials
Curcumin (Sigma-Aldrich, Canada), pyrrolidine-2 (Calbiochem, United States), temozolomide (Sigma-Aldrich, Canada), buthionine sulfoximine (Sigma-Aldrich, Canada), staurosporine (SigmaAldrich, Canada), dimethyl sulfoxide (Sigma-Aldrich, Canada), Nile Red (Sigma-Aldrich, Canada), paraformaldehyde (Sigma-Aldrich, Canada), BODIPY 493/503 (Invitrogen, Canada), Hoechst 33342 (Sigma-Aldrich, Canada) and propidium iodide (Sigma-Aldrich, Canada) were used as received.
Cell culture
The U251N human glioblastoma cell line was originally obtained from the American Type Culture Collection. Unless otherwise specified, U251N cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Invitrogen, Canada) containing 10% (v/v) fetal bovine serum (Invitrogen, Canada), 2 mM L-glutamine, 100 IU/mL penicillin, 100 lg/mL streptomycin (Invitrogen, Canada), and 1% non-essential amino acids. Cells were incubated at 37°C with 5% CO 2 .
Spheroid preparation
Spheroid cultures were prepared using a protocol adapted from the previously established liquid overlay system: confluent U251N monolayer cell cultures were detached using 0.05% trypsin-EDTA (Invitrogen, Canada), and seeded at 5,000 cells per well in 96-well plates pre-coated with 2% agarose (Invitrogen, Canada) in serum-deprived DMEM [44] . Spheroids were seeded and maintained in complete DMEM medium for four days before drug treatments. Spheroids expressing the caspase-3 biosensor were prepared following the same method, using transfected cells.
Cell treatment
Confluent monolayer cell cultures were detached using 0.05% trypsin-EDTA, seeded in 24-well or 96-well cell culture plates (Sarstedt, Canada) at 50,000 or 10,000 cells per well, respectively, and treated after 24 h. For 24 h dose-response experiments, drugs were administered in the following concentrations: curcumin (Cur; 5-100 lM); pyrrolidine-2 (Pyr-2; 1-5 lM). For 72 h dose-response experiments, curcumin was added at concentrations 5-30 lM. For pyrrolidine-2 (3 lM) and buthionine sulfoximine (BSO; 5 mM) pretreatments, cells were treated for 24 h, after which the medium was refreshed. To establish the time course of drug effects in spheroid cultures, treatments were maintained for 24 h or 72 h. BSO stocks (200 mM) were prepared fresh in purified water. Stock solutions of temozolomide, curcumin, staurosporine and pyrrolidine-2 were prepared in dimethyl sulfoxide (DMSO), and added to cells for a final DMSO concentration <0.5%. Vehicle controls were included in each experiment.
Lipid droplet labeling, imaging and quantification
After treatment with curcumin (10-30 lM) for 24 h, the media were refreshed, and cells were incubated with Nile Red (2 lM; 10 min). Nile red is a commonly used fluorescent label for lipid droplets [45, 46] , but it can also bind to hydrophobic protein domains and be employed to probe hydrophobic pockets in purified native proteins [47] . Labeled cells were washed with phosphate buffered saline (PBS), and imaged using a fluorescence microscope (Leica, Canada). To quantify the number of lipid droplets per cell, U251N cells were fixed with paraformaldehyde (4%; 15 min) following treatment, labeled with BODIPY 493/503 (2 lM; 10 min), and then imaged using a fluorescence microscope. 
Hoechst 33342 and propidium iodide labeling
In monolayer cultures, the culture medium was removed following treatment, and cells were fixed with paraformaldehyde (4%; 15 min). Cells were stained with Hoechst 33342 (10 lM; 10 min), and then washed and kept in PBS. Cell imaging was conducted using an automated microscopy platform (Operetta High Content Imaging System; Perkin Elmer, United States). Image analysis and cell counting were performed using the Columbus Image Data Storage and Analysis platform (Perkin Elmer, United States). In spheroid cultures, propidium iodide and Hoechst 33342 fluorescent dyes were added 3 h prior to measurements. At the end of treatment, individual spheroids were carefully transferred onto a microscope slide using a pipette, and flattened under a glass coverslip to facilitate imaging. Imaging was conducted using a fluorescence microscope, and fluorescence intensity was quantified using ImageJ.
Biosensor construction
The caspase-3 biosensor consists of two parts (Fig. 3) . Plasmid 1 encodes the green dimerization-dependent fluorescent protein (GA) linked with a nuclear exclusion signal sequence (NES; LALKLAGLDIGS) [48, 49] , the caspase-3 substrate sequence (DEVD) [50] , and a partner protein (B) linked to a nuclear localization signal (NLS; DPKKKRKVDPKKKRKVDPKKKRKV) [51] . Plasmid 2 encodes the dimerization-dependent red fluorescent protein (RA) linked with a NLS. Expression and purification of constructs 1 and 2 were performed according to procedures previously described in detail [38] . Details of the plasmid constructs are found in Table 1 .
Plasmid preparation and transfection
Stocks of the caspase-3 biosensor plasmids (kindly provided by Dr. Robert E. Campbell, University of Alberta, Canada) were prepared in a-Select Escherichia coli (Bioline, United States) using a Miniprep Kit (Qiagen, Canada). DNA concentration was adjusted to 1 lg/ll in purified water, and plasmids were stored at -20°C.
For transfection, U251N cells were seeded in black 96-well plates (Corning, United States) at a density of 10,000 cells per well, and cultured for 24 h. Transfection was conducted in the absence of antibiotics, using Lipofectamine 2000 (Invitrogen, Canada), following the procedure recommended by the manufacturer. The transfection complexes were kept for 24 h, after which the medium was replaced by complete medium, and cells were treated.
Live cell imaging of the caspase-3 biosensor
Monolayer cells seeded in black 96-well cell culture plates were transfected with the biosensor, and treated for 24 h. Following treatment, cells were imaged using the Operetta High Content Imaging System to analyze green (eGFP) and red (Alexa 594) signals. Caspase-3 activity was quantified as the number of cells with red nuclei, and expressed as a percentage of total transfected cells (expressing green or red fluorescence). The absence of caspase-3 activity was quantified from the number of cells with green cytoplasm, and expressed in the same manner. Eleven fields were analyzed per well, with six wells per treatment group. Negative controls were non-transfected cells in the presence or absence of drugs. Following treatment, transfected spheroids were transferred onto microscope slides, flattened under glass coverslips, and imaged using a fluorescence microscope. Full spheroids were imaged and the number of cells with green fluorescence in the cytoplasm or red fluorescence in the nucleus was counted.
Statistical analysis
Each experiment was independently performed at least two or three times. Each treatment was performed in three samples (24-well plates) or six samples (96-well plates). All data are expressed as mean ± SEM values. Statistical significance was calculated using one-way ANOVA, followed by the Student's t-test. For multiple comparisons, Bonferroni corrections were applied.
Results
Curcumin is sequestered in lipid droplets
Due to its fluorescent properties, curcumin's intracellular localization can be visualized using a fluorescence microscope (488/509 nm). After treating U251N glioblastoma cells with curcumin (10 lm) for 4 h, green fluorescence was found diffused throughout the cells, located at cell membranes, and concentrated in numerous punctate in the cytoplasm (Fig. 1A) . Staining of curcumin-treated cells with Nile Red, a lipophilic stain for intracellular lipids, showed that curcumin co-localized with membrane lipids and lipid droplets. Given the importance of lipid droplets for cancer cells, we then employed pyrrolidine-2, an inhibitor of cPLA2a, to reduce lipid droplet number in glioblastoma cells. U251N cells normally contain lipid droplets and their number can be reduced using inhibitors of lipid droplet formation, or increased using fatty acids such as oleic acid (Fig. S1 ).
Pyrrolidine-2 treatment (3 lM; 24 h) reduced lipid droplet number to 52 ± 5.7% of untreated control levels (Fig. 1C) . Lipid droplet number in cells treated with both curcumin and pyrrolidine-2 was higher (82.3 ± 16.0%) than that of cells treated with pyrrolidine-2 alone.
Pyrrolidine-2 potentiates the cell killing effect of curcumin
We postulated that U251N glioblastoma cells would be more susceptible to the therapeutic effects of curcumin following the reduction of lipid droplet number by pyrrolidine-2. Cell viability measured by counting cell nuclei labeled with Hoechst 33342
showed that 25 lM of curcumin decreased cell number to 53.8 ± 2.8% after 24 h of treatment ( Fig. 2A and B) . In turn, pyrrolidine-2 alone did not induce any significant decrease in cell viability up to 4 lM (Fig. 2C) . Pre-treatment of U251N cells with pyrrolidine-2 potentiated the cell killing effect of curcumin. Notably, pre-treatment with pyrrolidine-2 (24 h) virtually abolished glioblastoma viability when followed by curcumin treatment (72 h) at concentrations above 20 lM (Fig. 2B) . In comparison, pyrrolidine-2 modestly increased the effectiveness of temozolomide, which was included as a clinically relevant comparator (Fig. S2) . The effect of pyrrolidine-2 as a sensitizer was compared to that of BSO. Although pre-treatment with BSO increased cell death at lower concentrations of curcumin, it did not substantially increase cell death at higher concentrations (Fig. S3 ).
Cell death induced by curcumin and pyrrolidine-2 is mediated by caspase-3
To investigate the mode of cell death induced by curcumin and pyrrolidine-2, we employed a newly developed biosensor for caspase-3 activation. This construct offers a highly sensitive method to detect caspase-3-mediated apoptosis in live cells. In the absence of caspase-3 activity, cells expressing the biosensor display green fluorescence in the cytoplasm. Following the activation of caspase-3, green fluorescence fades and red fluorescence increases in the cell nucleus. Thus, caspase-3 activity can be quantified by counting the number of cells with red fluorescence as a proportion of total transfected cells expressing either green or red fluorescence. Experiments showed that even under control conditions, a small proportion of cells (13.2 ± 1.4%) display caspase-3 activity. In turn, the positive control staurosporine, a potent activator of caspase-3, significantly increased the proportion of cells with a red nucleus (Fig. 3D) .
To compare the mode of cell death induced by curcumin and pyrrolidine-2-sensitized curcumin treatments, U251N cells transfected with the caspase-3 biosensor were treated with monoand combination therapies for 24 h. The results showed that although temozolomide, curcumin and pyrrolidine-2-sensitized treatments all significantly reduced cell viability in U251N cells, only curcumin (alone or in combination) significantly induced caspase-3-mediated cell death (Fig. 4B and C) .
Curcumin and pyrrolidine-2 are effective in glioblastoma spheroids
To further investigate the effectiveness of curcumin and pyrrolidine-2, we used glioblastoma spheroids cultures, which more closely represent brain tumors found in vivo. Following the preparation of U251N spheroids using cells transfected with the caspase-3 biosensor, spheroids were treated at drug concentrations found to be effective in monolayer experiments. Due to their 3D structure, spheroids were ''squashed" between two glass surfaces in order to disperse the cells and facilitate their imaging (Fig. 5A) . Both curcumin and curcumin combined with pyrrolidine-2 induced a time-dependent increase in caspase-3 activity. In contrast, cytotoxic concentrations of temozolomide did not induce caspase-3 activity, even after 72 h (Fig. 5B and C) .
To relate caspase-3 activity to overall cell viability, we used Hoechst 33342 and propidium iodide labeling to examine the importance of necrotic cell death (Fig. 6) . The results showed that a time-dependent increase in necrotic cell death was seen in response to temozolomide, curcumin and curcumin combined with pyrrolodine-2. Yet, the most dramatic increase was seen with the combination treatment, where the rate of necrotic cell death almost doubled from 24 h to 72 h of treatment ( Fig. 6B and C) .
Discussion
In the nervous system, the presence of lipid droplets in neurons is minimal, and is most noticeable in glia cells under physiological conditions. In many models of neurodegeneration, the excessive accumulation of lipid droplets in glial cells is a hallmark of disease and is linked to mitochondrial dysfunction [19] . In glioblastoma multiforme, the accumulation of lipid droplets serves to fuel tumor growth and resist therapeutic treatments. Aside from providing energy to resist stress induced by chemotherapeutic drugs, it appears that lipid droplets can also directly decrease the amount of drugs available at targets by sequestering them inside the core of the lipid droplets. We hypothesized that the pharmacological inhibition of lipid droplet formation and the reduction of lipid droplet number in glioblastoma cells are viable strategies to increase the effectiveness of lipophilic chemotherapeutic drugs such as curcumin. The mechanisms involved are summarized in Fig. 7 . Curcumin is a hydrophobic compound owing to its aromatic phenolic groups and methylene bridge [52, 53] . The high lipophilicity of curcumin is indicated by its octanol-water partition coefficient of 2.5 Â 10 4 M À1 [54, 55] . Curcumin's partition coefficient for 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) lipid bilayers and HEPES buffer was 2.4 Â 10 4 M À1 [56] . This high partition coefficient clearly indicates curcumin's preference for lipophilic cellular compartments. As such, it can rapidly cross cell membranes and localize in lipid droplets (Fig. 1A) . In contrast, analysis using Time-of-Flight Secondary Ion Mass Spectrometry (TOF-SIMS) showed that temozolomide did not localize in lipid droplets (data not shown). The inhibition of lipid droplet formation can thus serve two purposes: (1) to lower the capacity of glioblastoma cells to withstand curcumin-induced stress by reducing their energy stores, and (2) to reduce the amount of compartments where curcumin can be sequestered, thereby increasing drug availability at targets. Different kinds of delivery systems have been used to deliver curcumin to the brain and to glioblastoma in vivo [57] [58] [59] . Polymeric carriers have the potential to improve the stability and solubility of curcumin [60] [61] [62] . Our research group has previously reported the incorporation of curcumin into A2B star polymer micelles and effectiveness of this preparation in glioblastoma [63, 64] . A retention of curcumin's biological activity in nanocarriers, an enhanced permeability and retention (EPR) effect and diffusion of curcumin into the neighboring glioblastoma cells could provide an improved therapeutic intervention in vivo [65] Pyrrolidine-2 is an inhibitor of cPLA2a, a key rate limiting enzyme in the synthesis of eicosanoids and a necessary player in the formation of lipid droplets [66, 67] . In normal brain tissues, particularly in astrocytes and microglia, excessive PLA2 activation in response to stressors (e.g. glutamate excitotoxicity) can exacerbate inflammatory processes and oxidative stress. In turn, these can promote neurological disorders such as Alzheimer's disease, Parkinson's disease, and traumatic brain injuries [68] . In glioblastoma cells, cPLA2a activity is likely to be upregulated in response to chemotherapeutic intervention, allowing cancer cells to stock up in energy and adapt their metabolic pathways. Although pyrrolidine-2 treatment alone does not induce significant loss in cell viability in U251N glioblastoma cells up to 4 lM, its effect becomes apparent when followed by curcumin treatments. Our results show that pyrrolidine-2 pre-treatment dramatically increased the effectiveness of curcumin in U251N cells after 72 h, virtually abolishing cell viability at curcumin concentrations above 20 lM. Interestingly, the lipid droplet number of cells treated with curcumin following pyrrolidine-2 sensitization was higher than that of cells treated with curcumin alone -likely due to the drug-induced cellular stress, previously reported to induce lipid droplet formation [19, 69, 70] . Sensitization using BSO was comparatively less effective, likely due to the diversity of antioxidants and enzymes that can reduce ROS levels. Nevertheless, the depletion of glutathione by BSO increased curcumin-mediated cell death, possibly through the increased peroxidation of lipid droplets, and necrosis (Fig. 7 ) [71] .
To investigate the mode of cell death induced by curcumin and pyrrolidine-2, we employed a highly sensitive biosensor to detect and measure caspase-3 activity in live cells [38] . The mechanism of the biosensor relies on a bi-modular design, in which two fluorescent proteins with dimerization-dependent brightness are activated in a mutually-exclusive manner. When challenged with proapoptotic stimuli, cells transfected with the biosensor manifest a change in fluorescence color, from green to red, and in signal localization, from the cytosol to the nucleus. In the absence of caspase-3 activity, the green cytoplasmic protein is linked with a nonfluorescent partner protein which increases green fluorescence manyfolds. Following the activation of caspase-3 during apoptosis, the caspase-3 substrate (DEVD) contained in the linker region is cleaved, and green fluorescence is dramatically decreased. The partner protein then translocates into the nucleus and associates with high affinity to the red fluorescent protein, enhancing red fluorescence manyfold. Thus, the specificity of detection is based on (1) the caspase-3 substrate, (2) the change in the color of the signal, and (3) the change in the subcellular localization of the signal. It is to note that a small proportion of cells display caspase-3 activity under control conditions. Our results support previous findings stating that curcumin is a strong inducer of caspase-3-mediated apoptosis in cancer cells [41, 42] . In contrast, temozolomideinduced cell death did not implicate caspase-3 activation, suggesting the involvement of other modes of cell death, such as autophagy [72] . Autophagy is usually reduced in cells with a large number of lipid droplets, which could partly explain the limited effectiveness of temozolomide against glioblastoma tumors [73, 74] .
In normal brain tissues, it appears that cPLA2a and lipid droplets play protective roles, notably helping glia cells to support neurons and resist stressors. For example, cPLA2a (+/+) mice were found to be more resistant to hypoxic conditions resulting from brain ischemia than their null counterparts [75] . Excessive cPLA2a activity has also been involved in apoptosis, as it was found to drive arachidonic acid-mediated cytotoxicity and subsequent caspase-3 activation [76] . On the other hand, the protective role of lipid droplets in glioblastoma cells is highly detrimental to cancer patients. The inhibition of cPLA2a is one of several approaches recently investigated to hinder lipid metabolism in cancer cells. Small molecules and gene silencing (e.g. acetyl-CoA carboxylase alpha) were shown to be effective in inhibiting cancer cell proliferation and viability in vitro [77] [78] [79] . However, most experiments performed in monolayer cancer cell cultures do not accurately reflect the conditions found in in vivo, where the intercellular contact, tumor dynamics and overall heterogeneous microenvironment Fig. 7 . Proposed mechanisms of drug action for curcumin and pyrrolidine-2-sensitization. Curcumin is a pluripotent agent. It induces apoptosis mainly through the activation of caspase-3-mediated apoptosis. Lipid droplets (LD) can sequester curcumin, reducing the availability and effectiveness of the drug. Sensitization of glioblastoma cells with pyrrolidine-2, an inhibitor of cPLA2a and of lipid droplet formation, can increase curcumin's availability at targets and cell death. In combination with BSO, curcumin also induces necrosis by reducing the levels of the scavenger glutathione (GSH), thereby increasing reactive oxygen species (ROS), leakage of peroxidized lipids from lipid droplets, and cell death.
found in tumors often heighten resistance to radiotherapy and chemotherapy [80] [81] [82] . Glioblastoma spheroids harbor hypoxic cores where metabolic pathways, including those involving lipids, are changed [4, [83] [84] [85] . De novo lipogenesis, for instance, was shown to be bypassed in cancer cells in hypoxic conditions. Instead, cancer cells relied on extracellular lipid scavenging to supply for their needs [6] . Thus, we conducted experiments in 3D spheroid, and confirmed that pyrrolidine-2 pre-treatment enhanced the cell killing effect of curcumin in a time-and caspase-3-dependent manner. In contrast, temozolomide alone was significantly less effective at inducing caspase-3 activation and glioblastoma cell death.
Because of the importance of cPLA2a in lipid metabolism and the production of pro-inflammatory mediators, its inhibition has also been studied in the context of inflammatory conditions such as arthritis [86, 87] . The microenvironment of glioblastoma tumors is characterized by the infiltration of hyperactivated immune cells, which aggravate disease progression. Thus, it can be hypothesized that inhibition of lipid metabolism can also reduce inflammation at tumor sites [88] [89] [90] . However, the potential side effects of pyrrolidine-2 deter its use in vivo. One of the best tolerated statins is simvastatin [91] . Statins were tested in some CNS diseases and were suggested as supplemental anticancer agents [92, 93] . Thus, the administration of simvastatin in combination with curcumin might be a suitable therapeutic strategy for certain groups of glioblastoma patients.
Taken together, our results indicate that lipid droplets in glioblastoma cells play a protective role by sequestering drugs and promoting cell survival. Decreased lipid droplet formation using pyrrolidine-2 as a sensitizing agent significantly increases the cell killing effect of chemotherapeutic agents such as curcumin.
